These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30242950)

  • 1. Thrombogenicity assessment of Pipeline Flex, Pipeline Shield, and FRED flow diverters in an in vitro human blood physiological flow loop model.
    Girdhar G; Andersen A; Pangerl E; Jahanbekam R; Ubl S; Nguyen K; Wainwright J; Wolf MF
    J Biomed Mater Res A; 2018 Dec; 106(12):3195-3202. PubMed ID: 30242950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombogenicity of flow diverters in an ex vivo shunt model: effect of phosphorylcholine surface modification.
    Hagen MW; Girdhar G; Wainwright J; Hinds MT
    J Neurointerv Surg; 2017 Oct; 9(10):1006-1011. PubMed ID: 27799376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombogenicity assessment of Pipeline, Pipeline Shield, Derivo and P64 flow diverters in an in vitro pulsatile flow human blood loop model.
    Girdhar G; Ubl S; Jahanbekam R; Thinamany S; Belu A; Wainwright J; Wolf MF
    eNeurologicalSci; 2019 Mar; 14():77-84. PubMed ID: 30723811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical safety and efficacy evaluation of the Pipeline Vantage Embolization Device with Shield Technology.
    Starke RM; Thompson J; Pagani A; Choubey A; Wainwright JM; Wolf MF; Jahanbekam R; Girdhar G
    J Neurointerv Surg; 2020 Oct; 12(10):981-986. PubMed ID: 32487767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly(2-methoxyethyl acrylate) (PMEA) improves the thromboresistance of FRED flow diverters: a thrombogenic evaluation of flow diverters with human blood under flow conditions.
    Yoshizawa K; Kobayashi H; Kaneki A; Takenouchi M; Belletto J; Baldwin A; Anzai T
    J Neurointerv Surg; 2023 Oct; 15(10):1001-1006. PubMed ID: 36180206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro thrombogenicity assessment of flow diversion and aneurysm bridging devices.
    Girdhar G; Li J; Kostousov L; Wainwright J; Chandler WL
    J Thromb Thrombolysis; 2015 Nov; 40(4):437-43. PubMed ID: 25975924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Pipeline Embolization Device and Flow Re-Direction Endoluminal Device Flow Diverters for Internal Carotid Artery Aneurysms: A Propensity Score-Matched Cohort Study.
    Griessenauer CJ; Thomas AJ; Enriquez-Marulanda A; Deshmukh A; Jain A; Ogilvy CS; Kocer N; Engelhorn T; Möhlenbruch M; Holtmannspötter M; Janssen H; Finkenzeller T; Reith W; Sonnberger M; Buhk JH; Schirmer CM; Killer-Oberpfalzer M
    Neurosurgery; 2019 Aug; 85(2):E249-E255. PubMed ID: 30541114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and Effectiveness of the Pipeline Flex Embolization Device With Shield Technology for the Treatment of Intracranial Aneurysms: Midterm Results From a Multicenter Study.
    Trivelato FP; Wajnberg E; Rezende MTS; Ulhôa AC; Piske RL; Abud TG; de Castro-Afonso LH; Abath CGC; Nakiri GS; Araújo JFS; Silva JLJ; Tosello RT; Vanzin JR; Manzato LB; Baccin CE; da Mota BAA; Abud DG
    Neurosurgery; 2020 Jul; 87(1):104-111. PubMed ID: 31504821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience using pipeline embolization device with Shield Technology in a patient lacking a full postoperative dual antiplatelet therapy regimen.
    Orlov K; Kislitsin D; Strelnikov N; Berestov V; Gorbatykh A; Shayakhmetov T; Seleznev P; Tasenko A
    Interv Neuroradiol; 2018 Jun; 24(3):270-273. PubMed ID: 29378449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First US experience with Pipeline Flex with Shield Technology using aspirin as antiplatelet monotherapy.
    Hanel RA; Aguilar-Salinas P; Brasiliense LB; Sauvageau E
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28473431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of neointima development in flow diverters using optical coherence tomography imaging.
    Matsuda Y; Chung J; Lopes DK
    J Neurointerv Surg; 2018 Feb; 10(2):162-167. PubMed ID: 28592484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome Study of the Pipeline Embolization Device with Shield Technology in Unruptured Aneurysms (PEDSU).
    Atasoy D; Kandasamy N; Hart J; Lynch J; Yang SH; Walsh D; Tolias C; Booth TC
    AJNR Am J Neuroradiol; 2019 Dec; 40(12):2094-2101. PubMed ID: 31727754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Flow-Redirection Endoluminal Device and Pipeline Embolization Device in the Treatment of Intracerebral Aneurysms.
    El Naamani K; Saad H; Chen CJ; Abbas R; Sioutas GS; Amllay A; Yudkoff CJ; Carreras A; Sambangi A; Hunt A; Jain P; Dougherty J; Tjoumakaris SI; Gooch MR; Herial NA; Rosenwasser RH; Zarzour H; Schmidt RF; Jabbour PM
    Neurosurgery; 2023 Jan; 92(1):118-124. PubMed ID: 36170173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Thromboembolic Events Between Pipeline Embolization Device (PED) Shield and PED/PED Flex: A Propensity Score-Matched Analysis.
    Ramirez-Velandia F; Enriquez-Marulanda A; Filo J; Young M; Fodor TB; Sconzo D; Muram S; Granstein JH; Shutran M; Taussky P; Ogilvy CS
    Neurosurgery; 2024 Aug; 95(2):330-338. PubMed ID: 38391195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intracranial aneurysms using the pipeline flex embolization device with shield technology: angiographic and safety outcomes at 1-year follow-up.
    Martínez-Galdámez M; Lamin SM; Lagios KG; Liebig T; Ciceri EF; Chapot R; Stockx L; Chavda S; Kabbasch C; Faragò G; Nordmeyer H; Boulanger T; Piano M; Boccardi EP
    J Neurointerv Surg; 2019 Apr; 11(4):396-399. PubMed ID: 30262655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on flow diverters for the endovascular management of cerebral aneurysms.
    Rajah G; Narayanan S; Rangel-Castilla L
    Neurosurg Focus; 2017 Jun; 42(6):E2. PubMed ID: 28565980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First U.S. Experience Using the Pipeline Flex Embolization Device with Shield Technology for Treatment of Intracranial Aneurysms.
    Cappuzzo JM; Monteiro A; Taylor MN; Waqas M; Baig AA; Almayman F; Davies JM; Snyder KV; Siddiqui AH; Levy EI
    World Neurosurg; 2022 Mar; 159():e184-e191. PubMed ID: 34920157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pipeline Embolization Device with Shield Technology for Intracranial Aneurysms: An Initial U.S. Experience.
    Griessenauer CJ; Goren O; Dalal SS; Schirmer CM
    World Neurosurg; 2018 Nov; 119():10-14. PubMed ID: 30075266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Diverters with Surface Modification in Patients with Intracranial Aneurysms: A Systematic Review and Meta-Analysis.
    Ma L; Hoz SS; Al-Bayati AR; Nogueira RG; Lang MJ; Gross BA
    World Neurosurg; 2024 May; 185():320-326.e17. PubMed ID: 38160909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow diverter surface modifications for aneurysm treatment: A review of the mechanisms and data behind existing technologies.
    White TG; Santhumayor BA; Turpin J; Shah K; Toscano D; Teron I; Link T; Patsalides A; Woo HH
    Interv Neuroradiol; 2023 Oct; ():15910199231207550. PubMed ID: 37899636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.